Telehealth company Ro launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S.
As if! ‘Clueless' star Alicia Silverstone avoids buying retail to limit environmental toll: ‘It needs to be used first' Ro chose to make the tool free for anyone to use because a"basic inventory management system" for GLP-1s does not exist, making it a major contribution to the broader community that relies on those medications, according to Reitano. He added that opening up the tracker to everyone also makes it more likely for both Ro patients and people not enrolled in the company's programs to access GLP-1s.about availability or a shortage of a GLP-1 at a specific pharmacy in their area.
Reitano said Ro has been building the GLP-1 tracker for about two months. The company hasn't been collaborating with the FDA directly, but providing the agency more real-time data can help it keep its shortage list as up to date as possible, he said. Individuals can sign up to receive automated email alerts about when a specific GLP-1 drug becomes available at a nearby pharmacy. The tracker also alerts patients about changes to the supply of a GLP-1 on the FDA's drug shortage database.
Switzerland Neuesten Nachrichten, Switzerland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »